Home
About Us
Why Raglan
Careers
Selected Transactions
Fundraising and Financial Support
Raglan IPO Projects
Raglan Pharmaceutical & Life Science Projects
Raglan Natural Resources
News
Contact us
Search
Uncategorized
Open Orphan in German pharma deal
Open...
by lynchski
Open Orphan signs 'significant' revenue generating contract
Open...
by lynchski
Open Orphan in line to take stake in '$1bn' flu drug
Open...
by lynchski
Amryt says integration of acquired company Aegerion ‘progressing well’
Amryt...
by lynchski
Open Orphan recruits hVIVO for its rare disease mission
Open...
by lynchski
Open Orphan to buy hVIVO in £30m merger deal
Open...
by lynchski
Open Orphan signs early adopters for health databank
Open...
by lynchski
Open Orphan partnership with Ipsen Group 'already delivering substantial revenues'
Open...
by lynchski
Amryt buys Aegerion via bankruptcy, adding sales to support R&D
Amryt...
by lynchski
Amryt Pharma co-founder welcomes 'transformational' Aegerion acquisition
Amryt...
by lynchski
1
2
3
…
5
